Skip to main content

LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin

Written by Customer Service on . Posted in Public Companies.

Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth

Carl Gustin, Chief Strategy & Marketing Officer, SpeciCare

Carl Gustin appointed to LiveWorld Board of Directors
Carl Gustin appointed to LiveWorld Board of Directors

CAMPBELL, Calif., and NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — LiveWorld, Inc. (OTC Markets: LVWD), a leading social-first digital agency specializing in compliance, engagement and insight solutions for healthcare and pharma brands, today announced the appointment of Carl Gustin to its Board of Directors. Gustin brings broad experience in healthcare, technology, and AI-driven business transformation, positioning LiveWorld for accelerated growth and innovation in the pharmaceutical and healthcare sectors.

Gustin currently serves as Chief Strategy & Marketing Officer at SpeciCare – New Options in Cancer Care. A recognized industry leader, he has held senior marketing and business management roles across global corporations, emerging brands, and agencies, shaping market strategies that have driven substantial business growth. His tenure as Chief Marketing Officer at Kodak saw him lead the company’s digital transformation. Additionally, he played a pivotal role in launching Apple’s first PowerBook and has been honored as an Ad Age Top 50 Marketer.

“Carl’s expertise in healthcare, technology, and driving the application and integration of AI-driven business and marketing solutions makes him an invaluable addition to LiveWorld’s Board,” said Peter Friedman, Chairman and CEO of LiveWorld. “His strategic insights and leadership will strengthen our ability to expand our client portfolio, bring to market innovative AI solutions, and further establish LiveWorld as a key player in the healthcare and pharma marketing space.”

Gustin’s appointment reinforces LiveWorld’s commitment to evolving its AI-driven solutions and deepening its footprint in the healthcare industry. With over 28 years of experience in transforming customer relationships through digital engagement, LiveWorld continues to empower leading pharmaceutical and healthcare brands with innovative, compliant, and effective social media strategies.

For more information about LiveWorld and its Board of Directors, visit www.liveworld.com.

About LiveWorld:
LiveWorld is a social-first digital agency that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers with bold, strategy-driven creative that captivates audiences, along with AI-powered software, social moderation, and compliance solutions tailored for healthcare and pharma.

With over 28 years of expertise, LiveWorld delivers emotion-driven behavior change through digital campaigns with a human touch. Our clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City.

For media inquiries, please contact:
Matthew Hammer
mhammer@liveworld.com
(737) 212-9739

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2734e79a-51b1-484c-b675-ea1873bb93ce

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.